| Methodological guidelines to study extracellular vesicles FAW Coumans, AR Brisson, EI Buzas, F Dignat-George, EEE Drees, ... Circulation research 120 (10), 1632-1648, 2017 | 1042 | 2017 |
| Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer RJA Nilsson, N Karachaliou, J Berenguer, A Gimenez-Capitan, ... Oncotarget 7 (1), 1066, 2015 | 208 | 2015 |
| Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients MAJ van Eijndhoven, JM Zijlstra, NJ Groenewegen, EEE Drees, ... JCI insight 1 (19), e89631, 2016 | 182 | 2016 |
| Detection and localization of early-and late-stage cancers using platelet RNA S GJG, M Arkani, E Post, M Antunes-Ferreira, S D’Ambrosi, DCL Vessies, ... Cancer Cell 40 (9), 999-1009. e6, 2022 | 63 | 2022 |
| In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin’s lymphoma and facilitates ultrasensitive residual disease detection S Sobesky, L Mammadova, M Cirillo, EEE Drees, J Mattlener, H Dörr, ... Med 2 (10), 1171-1193. e11, 2021 | 53 | 2021 |
| The impact of semiautomatic segmentation methods on metabolic tumor volume, intensity, and dissemination radiomics in 18F-FDG PET scans of patients with classical Hodgkin lymphoma J Driessen, GJC Zwezerijnen, H Schöder, EEE Drees, MJ Kersten, ... Journal of Nuclear Medicine 63 (9), 1424-1430, 2022 | 41 | 2022 |
| Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma EEE Drees, MGM Roemer, NJ Groenewegen, J Perez‐Boza, ... Journal of extracellular vesicles 10 (9), e12121, 2021 | 32 | 2021 |
| Circulating miRNAs as biomarkers in aggressive B cell lymphomas EEE Drees, DM Pegtel Trends in cancer 6 (11), 910-923, 2020 | 28 | 2020 |
| Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP J Driessen, MJ Kersten, L Visser, A van den Berg, SH Tonino, JM Zijlstra, ... Leukemia 36 (12), 2853-2862, 2022 | 11 | 2022 |
| PCR-free shallow whole genome sequencing for chromosomal copy number detection from plasma of cancer patients is an efficient alternative to the conventional PCR-based approach JJ Beagan, EEE Drees, P Stathi, PP Eijk, L Meulenbroeks, F Kessler, ... The Journal of Molecular Diagnostics 23 (11), 1553-1563, 2021 | 10 | 2021 |
| Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma EEE Drees, J Driessen, GJC Zwezerijnen, SAWM Verkuijlen, JJ Eertink, ... EJHaem 3 (3), 908-912, 2022 | 9 | 2022 |
| Exhaustive circulating tumor DNA sequencing reveals the genomic landscape of Hodgkin lymphoma and facilitates ultrasensitive detection of minimal residual disease S Sobesky, L Mammadova, M Cirillo, E Drees, J Mattlener, H Dörr, ... medRxiv, 2021.03. 16.21253679, 2021 | 7 | 2021 |
| Full-length tRNAs lacking a functional CCA tail are selectively sorted into the lumen of extracellular vesicles C Scheepbouwer, E Aparicio-Puerta, C Gómez-Martin, ... bioRxiv, 2024 | 3 | 2024 |
| Unbiased and UMI-informed sequencing of cell-free miRNAs at single-nucleotide resolution MAJ van Eijndhoven, E Aparicio-Puerta, C Gómez-Martín, JM Medina, ... bioRxiv, 2021.05. 04.442244, 2021 | 3 | 2021 |
| EML4-ALK rearrangement in blood platelets and outcome to crizotinib in non-small-cell lung cancer patients. N Karachaliou, RJA Nilsson, J Berenguer, A Gimenez Capitan, ... Journal of Clinical Oncology 33 (15_suppl), 8082-8082, 2015 | 3 | 2015 |
| Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment EEE Drees, YWS Jauw, E van Dijk, S Borchmann, SAWM Verkuijlen, ... HemaSphere 6 (7), e749, 2022 | 1 | 2022 |
| Cell-Free DNA Genomic and Fragmentomic Features for Early Outcome Prediction in Diffuse Large B-Cell Lymphoma S Wang, P Mapar, Y van der Pol, N Moldovan, NA Tantyo, ... Blood 144, 1588, 2024 | | 2024 |
| Towards IVDR‐compliance by implementing quality control steps in a quantitative extracellular vesicle‐miRNA liquid biopsy assay for response monitoring in patients with classic … EEE Drees, NJ Groenewegen, SAWM Verkuijlen, MAJ van Eijndhoven, ... Journal of Extracellular Biology 3 (7), e164, 2024 | | 2024 |
| Liquid Biopsy Strategies in Lymphoid Malignancies EEE Drees | | 2024 |
| Development of a Quality Management System-controlled plasma EV-miRNA assay for monitoring on-treatment disease activity in patients with classic Hodgkin Lymphoma EEE Drees, NJ Groenewegen, S Verkuijlen, MAJ van Eijndhoven, ... VU Research Portal, 107, 2023 | | 2023 |
